{
  "DOI": "10.1007/s12687-019-00428-5",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-019-00428-5",
  "alternative-id": [
    "428"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "18 December 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "14 June 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 July 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Deirdre Weymann, Nick Dragojlovic, and Samantha Pollard report no conflicts of interest. Dean A. Regier has received travel support from Illumina to attend conferences in Boston, USA, and Barcelona, Spain."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This article does not contain any studies with human participants or animals performed by any of the authors."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Weymann",
      "given": "Deirdre",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Dragojlovic",
      "given": "Nick",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pollard",
      "given": "Samantha",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-8876-0511",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Regier",
      "given": "Dean A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        7,
        5
      ]
    ],
    "date-time": "2019-07-05T01:02:32Z",
    "timestamp": 1562288552000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        3
      ]
    ],
    "date-time": "2022-10-03T20:12:25Z",
    "timestamp": 1664827945000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        9
      ]
    ],
    "date-time": "2024-02-09T22:01:28Z",
    "timestamp": 1707516088931
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2019,
        7,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            7,
            5
          ]
        ],
        "date-time": "2019-07-05T00:00:00Z",
        "timestamp": 1562284800000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            7,
            5
          ]
        ],
        "date-time": "2019-07-05T00:00:00Z",
        "timestamp": 1562284800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-019-00428-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-019-00428-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-019-00428-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "467-476",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        7,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        7,
        5
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.4103/0975-7406.160040",
      "author": "AA Agyeman",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "journal-title": "J Pharm Bioallied Sci",
      "key": "428_CR1",
      "unstructured": "Agyeman AA, Ofori-Asenso R (2015) Perspective: does personalized medicine hold the future for medicine? J Pharm Bioallied Sci 7:239–244",
      "volume": "7",
      "year": "2015"
    },
    {
      "key": "428_CR2",
      "unstructured": "AHS (2017) Breast Cancer Molecular Testing – Oncologist Alberta Health Services. https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-moleculartesting-bulletin.pdf. Accessed 29/10/2018"
    },
    {
      "DOI": "10.1002/cncr.30618",
      "author": "CH Barcenas",
      "doi-asserted-by": "publisher",
      "first-page": "2422",
      "journal-title": "Cancer",
      "key": "428_CR3",
      "unstructured": "Barcenas CH, Raghavendra A, Sinha AK, Syed MP, Hsu L, Patangan MG Jr, Chavez-MacGregor M, Shen Y, Hortobagyi GH, Valero V, Giordano SH, Ueno NT, Tripathy D (2017) Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay. Cancer 123:2422–2431",
      "volume": "123",
      "year": "2017"
    },
    {
      "key": "428_CR4",
      "unstructured": "BC Cancer (2016) New genetic tests become standard of cancer care in BC. BC Cancer. http://www.bccancer.bc.ca/about/news-stories/news/2016/new-genetic-tests-become-standard-of-cancer-care-in-bc. Accessed 29 Oct 2018"
    },
    {
      "DOI": "10.1038/nature12627",
      "author": "PL Bedard",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "Nature",
      "key": "428_CR5",
      "unstructured": "Bedard PL, Hansen AR, Ratain MJ, Siu LL (2013) Tumour heterogeneity in the clinic. Nature 501:355–364",
      "volume": "501",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmedgenet-2015-103144",
      "author": "K Boycott",
      "doi-asserted-by": "publisher",
      "first-page": "431",
      "journal-title": "J Med Genet",
      "key": "428_CR6",
      "unstructured": "Boycott K, Hartley T, Adam S, Bernier F, Chong K, Fernandez BA, Friedman JM, Geraghty MT, Hume S, Knoppers BM, Laberge AM, Majewski J, Mendoza-Londono R, Meyn MS, Michaud JL, Nelson TN, Richer J, Sadikovic B, Skidmore DL, Stockley T, Taylor S, van Karnebeek C, Zawati MH, Lauzon J, Armour CM, Canadian College of Medical Geneticists (2015) The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. J Med Genet 52:431–437",
      "volume": "52",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jval.2010.11.013",
      "author": "JF Bridges",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "Value Health",
      "key": "428_CR7",
      "unstructured": "Bridges JF et al (2011) Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 14:403–413",
      "volume": "14",
      "year": "2011"
    },
    {
      "DOI": "10.2217/pgs.13.183",
      "author": "J Buchanan",
      "doi-asserted-by": "publisher",
      "first-page": "1833",
      "journal-title": "Pharmacogenomics",
      "key": "428_CR8",
      "unstructured": "Buchanan J, Wordsworth S, Schuh A (2013) Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics 14:1833–1847",
      "volume": "14",
      "year": "2013"
    },
    {
      "key": "428_CR9",
      "unstructured": "CADTH (2017) Guidelines for the economic evaluation of health technologies. Canada. 4th ed. Ottawa:"
    },
    {
      "DOI": "10.1016/j.healthpol.2010.02.005",
      "author": "JJ Carlson",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Health policy",
      "key": "428_CR10",
      "unstructured": "Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL (2010) Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health policy 96:179–190",
      "volume": "96",
      "year": "2010"
    },
    {
      "key": "428_CR11",
      "unstructured": "Centre for Clinical Genomics (n.d.) CC Genomics Hereditary Cancer Panel. http://www.ccgenomics.ca/hcp-panel.html. Accessed 29 Oct 2018"
    },
    {
      "DOI": "10.1136/esmoopen-2016-000124",
      "author": "MC Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "e000124",
      "journal-title": "ESMO open",
      "key": "428_CR12",
      "unstructured": "Cheung MC, Chan KK, Sabharwal M, Fields A, Chambers A, Evans WK (2016) Comparing assessment frameworks for cancer drugs between Canada and Europe: what can we learn from the differences? ESMO open 1:e000124",
      "volume": "1",
      "year": "2016"
    },
    {
      "DOI": "10.1097/FPC.0000000000000061",
      "author": "S Cuffe",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Pharmacogenet Genomics",
      "key": "428_CR13",
      "unstructured": "Cuffe S, Hon H, Qiu X, Tobros K, Wong CKA, de Souza B, McFarlane G, Masroor S, Azad AK, Hasani E, Rozanec N, Leighl N, Alibhai S, Xu W, Issa AM, Liu G (2014) Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing. Pharmacogenet Genomics 24:348–355",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2017.226",
      "author": "N Dragojlovic",
      "doi-asserted-by": "publisher",
      "first-page": "1013",
      "journal-title": "Genet Med",
      "key": "428_CR14",
      "unstructured": "Dragojlovic N, Elliott AM, Adam S, van Karnebeek C, Lehman A, Mwenifumbo JC, Nelson TN, du Souich C, Friedman JM, Lynd LD (2018a) The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study. Genet Med 20:1013–1021",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1111/jep.12876",
      "author": "N Dragojlovic",
      "doi-asserted-by": "publisher",
      "first-page": "416",
      "journal-title": "J Eval Clin Pract",
      "key": "428_CR15",
      "unstructured": "Dragojlovic N, Kim E, Elliott AM, Study C, Friedman JM, Lynd LD (2018b) Evaluating the use of parental reports to estimate health care resource utilization in children with suspected genetic disorders. J Eval Clin Pract 24:416–422",
      "volume": "24",
      "year": "2018"
    },
    {
      "key": "428_CR16",
      "unstructured": "Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW (2015) Methods for the economic evaluation of health care programmes. Oxford university press"
    },
    {
      "DOI": "10.1016/j.jval.2012.05.006",
      "author": "E Faulkner",
      "doi-asserted-by": "publisher",
      "first-page": "1162",
      "journal-title": "Value Health",
      "key": "428_CR17",
      "unstructured": "Faulkner E, Annemans L, Garrison L, Helfand M, Holtorf AP, Hornberger J, Hughes D, Li T, Malone D, Payne K, Siebert U, Towse A, Veenstra D, Watkins J (2012) Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR Personalized Medicine Special Interest Group. Value Health 15:1162–1171",
      "volume": "15",
      "year": "2012"
    },
    {
      "key": "428_CR18",
      "unstructured": "Génome Québec (2016) A new initiative to facilitate the implementation of personalized medicine in Canada. Génome Québec. http://www.genomequebec.com/267-en/news-a-new-initiative-to-facilitate-the-implementation-of-personalized-medicine-in-canada/. Accessed 29 Oct 2018"
    },
    {
      "DOI": "10.1038/s41431-017-0020-3",
      "author": "RZ Hayeems",
      "doi-asserted-by": "publisher",
      "first-page": "1303",
      "journal-title": "Eur J Hum Genet",
      "key": "428_CR19",
      "unstructured": "Hayeems RZ, Bhawra J, Tsiplova K, Meyn MS, Monfared N, Bowdin S, Stavropoulos DJ, Marshall CR, Basran R, Shuman C, Ito S, Cohn I, Hum C, Girdea M, Brudno M, Cohn RD, Scherer SW, Ungar WJ (2017) Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. Eur J Hum Genet 25:1303–1312",
      "volume": "25",
      "year": "2017"
    },
    {
      "key": "428_CR20",
      "unstructured": "Health Quality Ontario (2018) Health technology assessments methods and process guide: version 2.0. https://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-methods-and-process-guide-en.pdf. Accessed 15 Feb 2019"
    },
    {
      "DOI": "10.1007/s40273-016-0416-x",
      "author": "A Hollis",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "journal-title": "PharmacoEconomics",
      "key": "428_CR21",
      "unstructured": "Hollis A (2016) Sustainable financing of innovative therapies: a review of approaches. PharmacoEconomics 34:971–980",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1186/1478-7547-11-6",
      "author": "D Husereau",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Cost Eff Resour Alloc",
      "key": "428_CR22",
      "unstructured": "Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E, on behalf of the CHEERS Task Force (2013) Consolidated health economic evaluation reporting standards (CHEERS) statement. Cost Eff Resour Alloc 11:6",
      "volume": "11",
      "year": "2013"
    },
    {
      "DOI": "10.1017/S0266462314000142",
      "author": "D Husereau",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Int J Technol Assess Health Care",
      "key": "428_CR23",
      "unstructured": "Husereau D, Marshall DA, Levy AR, Peacock S, Hoch JS (2014) Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making? Int J Technol Assess Health Care 30:179–187",
      "volume": "30",
      "year": "2014"
    },
    {
      "key": "428_CR24",
      "unstructured": "Joly Y, Ramos–Paque E (2010) Approval of new pharmacogenomic tests: is the Canadian regulatory process adequate? CJLT 8:2"
    },
    {
      "DOI": "10.1007/s11606-010-1515-6",
      "author": "Z Laksman",
      "doi-asserted-by": "publisher",
      "first-page": "204",
      "journal-title": "J Gen Intern Med",
      "key": "428_CR25",
      "unstructured": "Laksman Z, Detsky AS (2011) Personalized medicine: understanding probabilities and managing expectations. J Gen Intern Med 26:204–206",
      "volume": "26",
      "year": "2011"
    },
    {
      "DOI": "10.1111/cge.12077",
      "author": "M Lilley",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "journal-title": "Clin Genet",
      "key": "428_CR26",
      "unstructured": "Lilley M, Christian S, Blumenschein P, Chan S, Somerville M (2013) A centralized approach to out–of–province genetic testing leads to cost savings: the Alberta experience. Clin Genet 84:373–377",
      "volume": "84",
      "year": "2013"
    },
    {
      "DOI": "10.2217/pme.11.7",
      "author": "EO Lillie",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Per Med",
      "key": "428_CR27",
      "unstructured": "Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ (2011) The n–of–1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 8:161–173",
      "volume": "8",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2017.207",
      "author": "S Macklin",
      "doi-asserted-by": "publisher",
      "first-page": "346",
      "journal-title": "Genet Med",
      "key": "428_CR28",
      "unstructured": "Macklin S, Durand N, Atwal P, Hines S (2018) Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med 20:346–350",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1136/bmjopen-2015-010981",
      "author": "DA Marshall",
      "doi-asserted-by": "publisher",
      "journal-title": "BMJ Open",
      "key": "428_CR29",
      "unstructured": "Marshall DA, Deal K, Bombard Y, Leighl N, MacDonald KV, Trudeau M (2016) How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment. BMJ Open 6:e010981",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1186/1472-6963-13-454",
      "author": "M Najafzadeh",
      "doi-asserted-by": "publisher",
      "first-page": "454",
      "journal-title": "BMC Health Serv Res",
      "key": "428_CR30",
      "unstructured": "Najafzadeh M, Johnston KM, Peacock SJ, Connors JM, Marra MA, Lynd LD, Marra CA (2013) Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE). BMC Health Serv Res 13:454",
      "volume": "13",
      "year": "2013"
    },
    {
      "key": "428_CR31",
      "unstructured": "National Institutes of Health (2018) All of Us Research Program Operation Protocol. https://allofus.nih.gov/sites/default/files/aou operational protocol v1.7 mar 2018.pdf. Accessed 15/02/2019"
    },
    {
      "key": "428_CR32",
      "unstructured": "Newborn Screening Ontario (n.d.) Newborn Screening Ontario Molecular Diagnostics. https://www.newbornscreening.on.ca/en/diagnostic–testing/molecular–diagnostics. Accessed 29/10/2018"
    },
    {
      "DOI": "10.1016/j.jogc.2017.05.015",
      "author": "L Nshimyumukiza",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "journal-title": "J Obstet Gynaecol Can",
      "key": "428_CR33",
      "unstructured": "Nshimyumukiza L, Beaumont JA, Duplantie J, Langlois S, Little J, Audibert F, McCabe C, Gekas J, Giguère Y, Gagné C, Reinharz D, Rousseau F (2018) Cell-free DNA–based non-invasive prenatal screening for common aneuploidies in a Canadian Province: a cost-effectiveness analysis. J Obstet Gynaecol Can 40:48–60",
      "volume": "40",
      "year": "2018"
    },
    {
      "DOI": "10.1002/pd.4311",
      "author": "N Okun",
      "doi-asserted-by": "publisher",
      "first-page": "350",
      "journal-title": "Prenat Diagn",
      "key": "428_CR34",
      "unstructured": "Okun N, Teitelbaum M, Huang T, Dewa CS, Hoch JS (2014) The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for down syndrome in Ontario, Canada. Prenat Diagn 34:350–356",
      "volume": "34",
      "year": "2014"
    },
    {
      "key": "428_CR35",
      "unstructured": "Ontario Personalized Medicine Network (n.d.) Personalized Medicine Reports - Subcommittee 2: Evaluating Our Current Health Technology Assessment Capabilities in Light of Personalized Medicine Technologies. Ontario Genomics. http://www.ontariogenomics.ca/provincial-strategies/opmn/personalized-medicine-resources/. Accessed 29 Oct 2018"
    },
    {
      "DOI": "10.1038/s41576-019-0111-9",
      "doi-asserted-by": "crossref",
      "key": "428_CR36",
      "unstructured": "Pollard S, Sun S, Regier DA (2019) Balancing uncertainty with patient autonomy in precision medicine. Nat Rev Genet. 20:251–252"
    },
    {
      "DOI": "10.1001/jama.2018.9824",
      "author": "CJ Presley",
      "doi-asserted-by": "publisher",
      "first-page": "469",
      "journal-title": "Jama",
      "key": "428_CR37",
      "unstructured": "Presley CJ, Tang D, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Zhu W, Nussbaum NC, Sorg RA, Agarwala V, Abernethy AP, Gross CP (2018) Association of broad-based genomic sequencing with survival among patients with advanced non–small cell lung cancer in the community oncology setting. Jama 320:469–477",
      "volume": "320",
      "year": "2018"
    },
    {
      "DOI": "10.1111/j.1399-0004.2009.01193.x",
      "author": "D Regier",
      "doi-asserted-by": "publisher",
      "first-page": "514",
      "journal-title": "Clin Genet",
      "key": "428_CR38",
      "unstructured": "Regier D, Friedman J, Makela N, Ryan M, Marra C (2009) Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin Genet 75:514–521",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ajhg.2010.03.009",
      "author": "DA Regier",
      "doi-asserted-by": "publisher",
      "first-page": "765",
      "journal-title": "Am J Hum Genet",
      "key": "428_CR39",
      "unstructured": "Regier DA, Friedman JM, Marra CA (2010) Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86:765–772",
      "volume": "86",
      "year": "2010"
    },
    {
      "DOI": "10.1503/cmaj.140697",
      "author": "DA Regier",
      "doi-asserted-by": "publisher",
      "first-page": "E190",
      "journal-title": "Can Med Assoc J",
      "key": "428_CR40",
      "unstructured": "Regier DA, Peacock SJ, Pataky R, van der Hoek K, Jarvik GP, Hoch J, Veenstra D (2015) Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete–choice experiment. Can Med Assoc J 187:E190–E197",
      "volume": "187",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jval.2018.06.010",
      "author": "DA Regier",
      "doi-asserted-by": "publisher",
      "first-page": "1043",
      "journal-title": "Value Health",
      "key": "428_CR41",
      "unstructured": "Regier DA, Weymann D, Buchanan J, Marshall DA, Wordsworth S (2018) Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions. Value Health 21:1043–1047",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "428_CR42",
      "unstructured": "Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–423",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2016.12195",
      "author": "GD Sanders",
      "doi-asserted-by": "publisher",
      "first-page": "1093",
      "journal-title": "Jama",
      "key": "428_CR43",
      "unstructured": "Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG (2016) Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. Jama 316:1093–1103",
      "volume": "316",
      "year": "2016"
    },
    {
      "DOI": "10.1038/520609a",
      "author": "NJ Schork",
      "doi-asserted-by": "publisher",
      "first-page": "609",
      "journal-title": "Nature",
      "key": "428_CR44",
      "unstructured": "Schork NJ (2015) Personalized medicine: time for one-person trials. Nature 520:609–611",
      "volume": "520",
      "year": "2015"
    },
    {
      "key": "428_CR45",
      "unstructured": "Statistics Canada (2018) Table 18–10–0004–01 Consumer Price index, monthly, not seasonally adjusted. https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1810000401. Accessed 01 Oct 2018"
    },
    {
      "author": "EA Stuart",
      "first-page": "1",
      "journal-title": "J Inst Math Stat",
      "key": "428_CR46",
      "unstructured": "Stuart EA (2010) Matching methods for causal inference: a review and a look forward statistical science: a review. J Inst Math Stat 25:1",
      "volume": "25",
      "year": "2010"
    },
    {
      "DOI": "10.1038/gim.2017.47",
      "author": "K Tsiplova",
      "doi-asserted-by": "publisher",
      "first-page": "1268",
      "journal-title": "Genet Med",
      "key": "428_CR47",
      "unstructured": "Tsiplova K, Zur RM, Marshall CR, Stavropoulos DJ, Pereira SL, Merico D, Young EJ, Sung WWL, Scherer SW, Ungar WJ (2017) A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Genet Med 19:1268–1275",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1634/theoncologist.2009-0275",
      "author": "DT Tsoi",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Oncologist",
      "key": "428_CR48",
      "unstructured": "Tsoi DT, Inoue M, Kelly CM, Verma S, Pritchard KI (2010) Cost–effectiveness analysis of recurrence score–guided treatment using a 21–gene assay in early breast cancer. Oncologist 15:457–465",
      "volume": "15",
      "year": "2010"
    },
    {
      "DOI": "10.1136/bmj.k1687",
      "doi-asserted-by": "crossref",
      "key": "428_CR49",
      "unstructured": "Turnbull C et al (2018) The 100 000 genomes project: bringing whole genome sequencing to the NHS. BMJ 361:k1687"
    },
    {
      "DOI": "10.1002/mgg3.281",
      "author": "D Weymann",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Mol Genet Genom Med",
      "key": "428_CR50",
      "unstructured": "Weymann D, Laskin J, Roscoe R, Schrader KA, Chia S, Yip S, Cheung WY, Gelmon KA, Karsan A, Renouf DJ, Marra M, Regier DA (2017) The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Mol Genet Genom Med 5:251–260",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1200/PO.17.00311",
      "doi-asserted-by": "crossref",
      "key": "428_CR51",
      "unstructured": "Weymann D, Pataky R, Regier DA (2018) Economic evaluations of next–generation precision oncology: a critical review. JCO Precision Oncology 2:1–23"
    },
    {
      "DOI": "10.1007/s11568-007-9005-6",
      "author": "S Wordsworth",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Genomic Medicine",
      "key": "428_CR52",
      "unstructured": "Wordsworth S, Buchanan J, Regan R, Davison V, Smith K, Dyer S, Campbell C, Blair E, Maher E, Taylor J, Knight SJL (2007) Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom. Genomic Medicine 1:35–45",
      "volume": "1",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s40258-018-0390-x",
      "doi-asserted-by": "crossref",
      "key": "428_CR53",
      "unstructured": "Yuen T, Carter MT, Szatmari P, Ungar WJ (2018) Cost–effectiveness of genome and exome sequencing in children diagnosed with autism spectrum disorder Applied health economics and health policy 16:481–493"
    }
  ],
  "reference-count": 53,
  "references-count": 53,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-019-00428-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}